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a b s t r a c t
There is increasing evidence that N-methyl-D-aspartate (NMDA) receptor blockade in the neonatal period
has a long-lasting inﬂuence onbrain and behavior development andhas been linked to an increased risk for
neuropsychiatric disorders in later life. We sought to determine whether postnatal NMDA receptor
blockade can affect normal development of body weight, corticosterone levels, anxiety- and depression-
related behaviors in male and female mice in adulthood. For this purpose, male and female NMRI mice
were treatedwith either saline or phencyclidine (PCP; 5 and10mg/kg, s.c.) onpostnatal days (PND) 7, 9, and
11, and then subjected todifferent behavioral tests, including openﬁeld, elevated plus-maze, elevated zero-
maze, light-dark box, tail suspension test and forced swimming test in adulthood. The results indicated that
neonatal PCP treatment reduced body weight during neonatal and adulthood periods, and did not alter
baseline corticosterone levels in both male and female mice. Moreover, this study obtained some experi-
mental evidence showing the PCP at dose of 10 mg/kg increases stress-induced corticosterone levels,
anxiety- and depression-related behaviors in males, while decreasing levels of anxiety without any sig-
niﬁcant effect on depression in female mice in adulthood. These data support the argument that neonatal
NMDA receptor blockade can lead to behavioral abnormalities and psychiatric diseases in adulthood.
Collectively, our ﬁndings suggest that neonatal exposure to PCP may have profound effects on the devel-
opment of anxiety- and depression-related behaviors in a sex- and dose-dependent manner in mice.
! 2013 Elsevier Ltd. All rights reserved.
1. Introduction
The neonatal period is an important neurodevelopmental stage
to the understanding of the etiology and developmental trajectory
of neuropsychiatric disorders such as anxiety and depression in
later life. Epidemiological reports indicate that these behavioral
dysfunctions are complex and multifactorial disorders involving
both genetic and environmental factors (Anisman et al., 2008).
It was found that anxiety is often associated with depression
(Beuke et al., 2003) which is not surprising, considering the notion
that these disorders share a common genetic pathway (Kendler
et al., 2007; Williamson et al., 2005). There are fundamental dif-
ferences between male and female in many psychological and
behavioral aspects, and also the structure and morphology of the
brain in both sexes are highly similar. Hence, there are consistent
differences between themwith subsequent important implications
for each sex (Bao and Swaab, 2011; Ngun et al., 2011). For example,
anxiety and depression are almost twice as common in females as
in males (McLean and Anderson, 2009); however the factors
mediating these differences are not well understood.
A number of recent studies have demonstrated thatN-Methyl-D-
aspartate (NMDA) receptor plays an important role in normal brain
development and plasticity during early life (du Bois et al., 2009a;
du Bois and Huang, 2007; Lim et al., 2012). It has been documented
that the developing neurons strongly depend on NMDA receptor
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